Skip to main content

Covista Inc.

For the period ended Sep 30, 2026. Filed Oct 29, 2026.

View on SEC.gov

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Sep 30, 2026 · Filed Oct 29, 2026

CVSA$116.50+2.2%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Consolidated Statements of Cash Flows

(in thousands)

​​​​​​​
​ · ​ · Three Months Ended
​ · ​ · September 30,
​ · ​ · 2026 · ​ · 2025
Operating activities:​​​​​​
Net income​$67,427​$61,832
Loss (income) from discontinued operations​4,055​(770)
Income from continuing operations​​71,482​​61,062
Adjustments to reconcile net income to net cash provided by operating activities:​​​​
Stock-based compensation​8,181​8,293
Amortization of operating lease assets​​7,018​​7,216
Depreciation​10,862​10,296
Amortization of acquired intangible assets​1,394​2,805
Amortization and write-off of debt discount and issuance costs​​660​​1,145
Provision for credit losses​​22,402​​14,883
Deferred income taxes​8,798​54,413
Loss on disposals and impairments of property and equipment​—​2
Loss (gain) on investments​​218​​(680)
Changes in assets and liabilities:​​​​
Accounts and financing receivables​(94,219)​(62,690)
Prepaid expenses and other current assets​(10,788)​(29,841)
Cloud computing implementation assets​(3,292)​(4,812)
Accounts payable​(13,536)​1,378
Accrued payroll and benefits​​(20,886)​​(24,359)
Accrued liabilities​13,025​(12,287)
Deferred revenue​107,928​109,082
Operating lease liabilities​​10,548​​(4,317)
Other assets and liabilities​(5,524)​(960)
Net cash provided by operating activities-continuing operations​114,271​130,629
Net cash used in operating activities-discontinued operations​(233)​(80)
Net cash provided by operating activities​114,038​130,549
Investing activities:​​​​​
Capital expenditures​(37,592)​(16,023)
Proceeds from sales of marketable securities​—​100
Purchases of marketable securities​—​(100)
Net cash used in investing activities​(37,592)​(16,023)
Financing activities:​​​​​
Proceeds from exercise of stock options​—​131
Employee taxes paid on withholding shares​(16,203)​(39,119)
Proceeds from stock issued under Colleague Stock Purchase Plan​564​411
Repurchases of common stock for treasury​(81,002)​(7,595)
Repayments under long-term debt obligations​(163,000)​—
Payment of debt issuance costs​—​(3,333)
Net cash used in financing activities​(259,641)​(49,505)
Net (decrease) increase in cash, cash equivalents and restricted cash​(183,195)​65,021
Cash, cash equivalents and restricted cash at beginning of period​407,754​201,164
Cash, cash equivalents and restricted cash at end of period​$224,559​$266,185
Non-cash investing and financing activities:​​​​​​
Accrued capital expenditures​$17,969​$4,727
Accrued liability for repurchases of common stock​$3,000​$—
Accrued excise tax on share repurchases​$2,310​$1,630
Accrued debt issuance costs​$—​$437
ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.